Evidence map›Paper›PMID 25932463›Full record

ArticleAJOB empirical bioethics

"Don't Want No Risk and Don't Want No Problems": Public Understandings of the Risks and Benefits of Non-Invasive Prenatal Testing in the United States.

Megan Allyse, Lauren Carter Sayres, Taylor Goodspeed, Marsha Michie, Mildred K Cho

Abstract read
In one paragraph

Article in AJOB empirical bioethics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Resistance to Change.Reproductive sciences (Thousand Oaks, Calif.) · 2023
    Review
  7. Article
  8. Decisional regret in women receiving high risk or inconclusive prenatal cell-free DNA screening results.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2020
    Article
  9. Article
  10. 'Small cost to pay for peace of mind': Women's experiences with non-invasive prenatal testing.The Australian & New Zealand journal of obstetrics & gynaecology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Megan AllyseInstitute for Health and Aging, University of California San Francisco.
Lauren Carter SayresDuke University Medical School.
Taylor GoodspeedUniversity of Pennsylvania Law School.
Marsha MichieInstitute for Health and Aging, University of California San Francisco.
Mildred K ChoStanford Center for Biomedical Ethics and Department of Pediatrics, Stanford Medical School.

Funding

Center for Integration of Research on Genetics and EthicsP50HG003389 · NHGRI · STANFORD UNIVERSITY · PI CHO, MILDRED K. · 2004 to 2014
$9.9M
Mapping an ELSI-integrated translational pathway with cell-free fetal DNA testingR00HG006452 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MICHIE, MARSHA MABRY · 2014 to 2016
$747k
Mapping an ELSI-integrated translational pathway with cell-free fetal DNA testingK99HG006452 · NHGRI · STANFORD UNIVERSITY · PI MICHIE, MARSHA MABRY · 2012 to 2013
$171k
NHGRI NIH HHS K99 HG006452NHGRI NIH HHS P50 HG003389NHGRI NIH HHS R00 HG006452
6 · The paper itself

Abstract

backgroundThe recent availability of new non-invasive prenatal genetic tests for fetal aneuploidy has raised questions concerning whether and how these new tests will be integrated into prenatal medical care. Among the many factors to be considered are public understandings and preferences about prenatal testing mechanisms and the prospect of fetal aneuploidy.

methodsTo address these issues, we conducted a nation-wide mixed-method survey of 2,960 adults in the United States to explore justifications for choices among prenatal testing mechanisms. Open responses were qualitatively coded and grouped by theme.

resultsRespondents cited accuracy, followed by cost, as the most significant aspects of prenatal testing. Acceptance of testing was predicated on differing valuations of knowledge and on personal and religious beliefs. Trust in the medical establishment, attitudes towards risk, and beliefs about health and illness were also considered relevant.

conclusionsAlthough a significant portion of the sample population valued the additional accuracy provided by the new non-invasive tests, they nevertheless expressed concerns over high costs. Furthermore, participants continued to express reservations about the value of prenatal genetic information per se, regardless of how it was obtained.

Indexed as

AneuploidyPrenatal ScreeningPrenatal TestingPublic Attitudes

Identifiers

PMID25932463
PMCPMC4410992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.